Src SH2 binders (Aventis)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameSrc SH2 binders (Aventis)

Drug Alias NameSrc SH2 ligands (sanofi-aventis)RU-81843RU-79181RU-85052

ClassificationSmall molecules

Mechanisms of ActionBone modulatorsTyrosine-protein kinase SRC inhibitors

TargetsTyrosine-protein kinase SRC

Therapy Area/IndicationsOsteoporosisOsteopetrosisBone Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAventis Pharma Sa

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAventis Pharma Sa

Active IndicationsN/A

Inactive IndicationsOsteoporosisOsteopetrosisBone Diseases

ATC CodeN/A